A new MD-PhD collaboration between Yale and the University of Puerto Rico (UPR) is set expand the scope of research and clinical trials for both institutions.
Associate Professor of Cell Biology and Neuroscience Daniel Colón-Ramos, PhD, says that that by connecting researchers from each institution through their students, the new program “aspires to act as a spearhead to create clinical research links” between Yale and UPR.
Earlier in January, representatives from YCCI, including Director Robert Sherwin, MD, traveled to Puerto Rico and met with faculty and deans at UPR to discuss potential clinical research priorities and logistics for the collaboration. They also met with the Puerto Rico Science, Technology, & Research Trust (PRSTRT) to discuss conducting Yale-led clinical trials in Puerto Rico. Last summer, UPR officials made a similar trip to Yale, meeting with President Peter Salovey and touring Yale’s research facilities.